Literature DB >> 33396267

Delayed Exercise Training Improves Obesity-Induced Chronic Kidney Disease by Activating AMPK Pathway in High-Fat Diet-Fed Mice.

Florian Juszczak1,2, Maud Vlassembrouck1, Olivia Botton2, Thomas Zwakhals1, Morgane Decarnoncle1, Alexandra Tassin3, Nathalie Caron2, Anne-Emilie Declèves1.   

Abstract

Exercise training is now recognized as an interesting therapeutic strategy in managing obesity and its related disorders. However, there is still a lack of knowledge about its impact on obesity-induced chronic kidney disease (CKD). Here, we investigated the effects of a delayed protocol of endurance exercise training (EET) as well as the underlying mechanism in obese mice presenting CKD. Mice fed a high-fat diet (HFD) or a low-fat diet (LFD) for 12 weeks were subsequently submitted to an 8-weeks EET protocol. Delayed treatment with EET in obese mice prevented body weight gain associated with a reduced calorie intake. EET intervention counteracted obesity-related disorders including glucose intolerance, insulin resistance, dyslipidaemia and hepatic steatosis. Moreover, our data demonstrated for the first time the beneficial effects of EET on obesity-induced CKD as evidenced by an improvement of obesity-related glomerulopathy, tubulo-interstitial fibrosis, inflammation and oxidative stress. EET also prevented renal lipid depositions in the proximal tubule. These results were associated with an improvement of the AMPK pathway by EET in renal tissue. AMPK-mediated phosphorylation of ACC and ULK-1 were particularly enhanced leading to increased fatty acid oxidation and autophagy improvement with EET in obese mice.

Entities:  

Keywords:  AMPK; autophagy; chronic kidney disease; ectopic lipid accumulation; endurance exercise training; high-fat diet

Year:  2020        PMID: 33396267     DOI: 10.3390/ijms22010350

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  1 in total

1.  Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy.

Authors:  Xing Chen; Shuchun Chen; Zelin Li; Xiaoyu Pan; Yujiao Jia; Zhijuan Hu; Kai Niu; Bing Liu; Qingjuan Ren
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-20       Impact factor: 3.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.